Recursion Pharmaceuticals, Inc. RXRX Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue from Contract with Customer, Excluding Assessed Tax by Product | ||||||
| Grant revenue | $171K-8.6% | $187K-2.6% | $192K+60.0% | $120K+264% | -$73K-309% | |
| Operating revenue | $6.3M-82.2% | $35.35M+609% | $4.98M-73.9% | $19.1M+28.9% | $14.82M+228% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Recursion Pharmaceuticals, Inc. break its business down?
- Recursion Pharmaceuticals, Inc. (RXRX) reports revenue from contract with customer, excluding assessed tax by product across 2 parts — Grant revenue and Operating revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does Recursion Pharmaceuticals, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Recursion Pharmaceuticals, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
